Purchase Order 75F40120P00150
Award Date
4/10/20
Potential Completion Date
3/11/21
Potential Value
$7M
Federal Agency
Food and Drug Administration
Ultimate Awardee
Mckinsey & Company, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20903, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' Food and Drug Administration awarded a firm fixed-price contract to McKinsey & Company, Inc. Washington D.C. for the "COVID-19 Pandemic - Mid-Action Review Project (MAR)". The contract, which does not use a set-aside, has a potential value of $2,246,000.00 and a completion date of January 15, 2021. McKinsey & Company, a global management consulting firm, will provide strategic advisory services and support to the FDA related to the...
This federal contract award, valued at $477,346.58, was issued by the Food and Drug Administration (FDA) to the management consulting firm McKinsey & Company, Inc. Washington D.C. The contract is a Blanket Purchase Agreement (BPA) call under the General Services Administration's (GSA) Professional Services Schedule (PSS), with a firm fixed price pricing type. The contract is for organizational assessment services, with a period of performance ending on December 23, 2016. This award does...
This contract was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to McKinsey & Company, Inc. Washington D.C. as the prime contractor. The contract is a Blanket Purchase Agreement (BPA) call under the General Services Administration's (GSA) Professional Services Schedule (PSS), with a firm fixed price. The contract is for revamping the hiring process of the FDA's Office of Medical Products & Tobacco (OMPT), with a potential value of...
The Department of Health and Human Services Food and Drug Administration awarded a Firm Fixed Price contract to McKinsey & Company, Inc. Washington D.C. to support the FDA's OMPT Modernization Efforts and Reorganization Initiatives. The $1,513,559.55 contract, awarded on December 12, 2017, was issued under the General Services Administration's Professional Services Schedule (PSS). The contract, which has a completion date of May 16, 2018, does not have a set-aside designation. McKinsey &...
The U.S. Department of Health and Human Services' Food and Drug Administration (FDA) awarded a firm fixed-price Blanket Purchase Agreement (BPA) call to McKinsey & Company, Inc. Washington D.C., a management consulting firm, for the "CDER Integrated Sentinel Strategy & Operational Plan" project. The $960,839.38 contract, which has a completion date of August 31, 2018, was not set aside for any specific business type. The contract work was performed in Silver Spring, Maryland...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) Call contract to McKinsey & Company, Inc. Washington D.C. to provide CDER/CBER Hiring Pilot Support Services. The $4,579,261.26 contract is under the General Services Administration (GSA) Professional Services Schedule (PSS) contract vehicle and does not have a set-aside designation. McKinsey will perform the work in Silver Spring, Maryland, with...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price contract to McKinsey & Company, Inc. Washington D.C. for OCP Auditing Strategic Analysis and Roadmapping to Support Combination Products. The $1,969,083.75 contract, which was not set aside, was issued under the General Services Administration's Professional Services Schedule. McKinsey, a management consulting firm, has received over $500 million in federal contracts since 2008 to provide...
This is a firm-fixed price Blanket Purchase Agreement (BPA) call order awarded by the Department of Health and Human Services' Food and Drug Administration to McKinsey & Company, Inc. Washington D.C., a for-profit management consulting firm. The contract, valued at $1,357,646.57, is for a patient engagement strategy assessment and user experience evaluation to be performed at the agency's location in Silver Spring, Maryland. The contract is not set aside for a specific business type. The...
This is a firm fixed price BPA call contract awarded by the Food and Drug Administration (FDA) to McKinsey & Company, Inc. Washington D.C. for $1,493,644.43 to support the modernization of new drug reviews for the Center for Drug Evaluation and Research (CDER). The contract is under the GSA Professional Services Schedule (PSS) contract vehicle and has no set-aside designation. McKinsey & Company, a global management consulting firm, will provide strategic advisory services to the FDA...
The Department of Health and Human Services Food and Drug Administration awarded a Firm Fixed Price contract to McKinsey & Company, Inc. Washington D.C. to provide assessment and evaluation services for the FDA's Expanded Access and Compassionate Use Programs. The contract, which was issued under the Professional Services Schedule (PSS) indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle, has a potential value of $764,125.32 and a completion date of May 15, 2018. McKinsey &...